Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Oncology162.95M30.86%
Other112.43M21.29%
Metabolic106.3M20.13%
Cardiology60.7M11.49%
Central Nervous System46.52M8.81%
Antiviral and Anti-infective (AVAI)39.2M7.42%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States1.85B98.00%
North America, Europe, Asia, South America, Africa and Australia37.72M2.00%
